1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Alabama >
  6. Greer Capital Advisors Exits BioDtech

Investment Summary

Greer Capital Advisors Exits BioDtech

On November 28, 2018, CytoBioscience invested in life science company BioDtech from Greer Capital Advisors

Investment Highlights
  • This is CytoBioscience’s 2nd transaction in the Life Science sector.
  • This is CytoBioscience’s 2nd transaction in the United States.
  • This is CytoBioscience’s 2nd transaction in Alabama.
Investment Fate
  • BioDtech was divested to a consortium of strategic buyers in 2020.

Investment Summary
Date 2018-11-28
Target BioDtech
Sector Life Science
Investor(s) CytoBioscience
Sellers(s) Greer Capital Advisors
Deal Type Add-on Acquisition

Target

BioDtech

Birmingham, Alabama, United States
BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

CytoBioscience

San Antonio, Texas, United States
Category Company
Sector Medical Products
DESCRIPTION

CytoBioscience, Inc. is a manufacturer of devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: Alabama M&A 2 of 2
Country: United States M&A 2 of 2
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-20 Soluble Therapeutics

Birmingham, Alabama, United States

Soluble Therapeutics, Inc. specializes in the formulation optimization of protein-based therapeutics and vaccines on a contract basis for pharmaceutical, biotech, and vaccine companies.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-02 BioDtech

Birmingham, Alabama, United States

BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama.

Sell -

Seller(S) 1

SELLER

Greer Capital Advisors

Mountain Brook, Alabama, United States

Investor

Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Greer Capital Advisors (GCA) is a specialized, heathcare focused private equity firm that targets investments in Alabama based companies. Within healthcare, GCA looks for companies in the pharmaceutical, biotechnology, medical device, and diagnostics industries. GCA prefers early and growth stage investments and generally seeks to invest between $1 to $2 million per transaction. Greer Capital Advisors was formed in 2002 and is based in Birmingham, Alabama.

DEAL STATS #
Overall 13 of 13
Sector: Life Science M&A 10 of 10
Type: Add-on Acquisition M&A Deals 10 of 10
State: Alabama M&A 7 of 7
Country: United States M&A 13 of 13
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-20 Egen

Huntsville, Alabama, United States

Egen, Inc., operates biopharmaceutical company focused on developing nucleic acid-based therapeutics for cancer and other difficult to treat diseases using proprietary nanoparticle delivery systems. Egen was founded in 2002 and is based in Huntsville, Alabama.

Sell -
Mergr

Solution for

Product

Company

Legal